Skip to content
Screener

Total Revenue at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$11.99B—
Danaher logo
DanaherDHR
$6.27B+5.5%
Bruker logo
BrukerBRKR
$838.5M+5.2%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$151.04M-12.6%
Revvity logo
RevvityRVTY
$729.69M+1.3%
Agilent Technologies logo
Agilent TechnologiesA
$1.88B+8.1%

Segments

By product

See full
Consumables$260.73M+3.1%
Instruments$31.54M+9.1%
Service$23.06M-22.1%
Royalty$5.87M+6.5%

By geography

See full
US$176.39M—
CN$26.91M—
GB$14.79M—

By segment

See full
Protein Sciences$231.19M+2.1%
Diagnostics And Spatial Biology$90.14M+0.5%

Other financials

Income statement

See full
Gross profit$211.4M+6.3%
Operating income$74.3M—
Net income$54.6M—
EPS (diluted)$0.35—

Balance sheet

See full
Cash & equivalents$264.7M+63.2%
Total debt$289.1M-34.9%
Total equity$2.1B+9.9%
Total assets$2.6B+1.1%

Cash flow

See full
Operating cash flow$95.4M-2.8%
CapEx$8.5M+73.4%
Free cash flow$86.9M-6.8%

Valuation

See full
Market cap$11.35B+17.4%
Enterprise value$11.38B+14.7%
P/E62.4×—
P/S9.3×+1.4×

Profitability

See full
Gross margin65.8%+1.0pp
Operating margin20.7%—
Net margin15%—
FCF margin21.7%+0.6pp

Returns & leverage

See full
Return on equity9%—
Debt / equity0.1×-0.1×
Current ratio4.5×+1.1×

Where this comes from

Reported directly by Bio-Techne Corp. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bio-Techne Corp.’s 10-K, filed August 24, 2026.

Filed
Aug 24, 2026, 4:31 PM EDT
Fiscal year
FY2026
Accession
0001104659-26-100322
Line itemYear Ended June 30, 2026Year Ended June 30, 2025Year Ended June 30, 2024
Net sales$1,215,039$1,219,635$1,159,060
Cost of sales415,968429,363389,335
Gross margin799,071790,272769,725
Operating expenses:
Selling, general and administrative452,415588,521466,375
Research and development94,76699,49696,664
Total operating expenses547,181688,017563,039
Operating income251,890102,255206,686

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Bio-Techne Corp.'s total revenue?
Bio-Techne Corp. (TECH) reported total revenue of $321.19M in Q2 2026.
How has Bio-Techne Corp.'s total revenue changed year-over-year?
Bio-Techne Corp.'s total revenue increased by 1.3% year-over-year, from $316.96M to $321.19M.
What is the long-term trend for Bio-Techne Corp.'s total revenue?
Over 4 years (2022 to 2026), Bio-Techne Corp.'s total revenue has grown at a 2.4% compound annual growth rate (CAGR), from $1.11B to $1.22B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Bio-Techne Corp.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude